Table 2.

Descriptive statistics for entire population, individuals who were HCV-infected through viral load test, individuals who were entered into treatment, and individuals who have ongoing treatment or have completed treatment.

Characteristics	Screened N = 607	HCV-infected N = 94	Initiated treatment N = 57	Completed or ongoing treatment N = 50
Median age (IQR)	45 (35–58)	41 (34–57)	39 (33–53)	40 (32–56)
Age group
18–29	59 (9.7%)	5 (5.3%)	7 (12.3%)	7 (14.0%)
30–44	234 (38.6%)	49 (52.1%)	29 (50.9%)	23 (46.0%)
45–64	231 (38.1%)	32 (34%)	19 (33.3%)	18 (36.0%)
65 and over	78 (12.9%)	8 (8.5%)	2 (3.5%)	2 (4.0%)
Unknown	5 (0.8%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Sex
Female	258 (42.5%)	28 (29.8%)	19 (33.3%)	16 (32.0%)
Male	349 (57.5%)	66 (70.2%)	38 (66.7%)	34 (68.0%)
Race/ethnicity
Black	171 (28.2%)	20 (21.3%)	9 (15.8%)	9 (18.0%)
Hispanic	47 (7.7%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
White	372 (61.3%)	73 (77.7%)	47 (82.5%)	40 (80.0%)
Other	2 (0.4%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Unknown	15 (2.5%)	1 (1.1%)	1 (1.7%)	1 (2.0%)
Transportation
Bike	14 (2.3%)	3 (3.2%)	1 (1.8%)	1 (2.0%)
Car	277 (45.6%)	39 (41.5%)	27 (47.4%)	22 (44.0%)
Other car	41 (6.8%)	11 (11.7%)	7 (12.3%)	6 (12.0%)
Public Transportation	45 (7.4%)	10 (10.6%)	6 (10.5%)	6 (12.0%)
Scooter	7 (1.2%)	2 (2.1%)	2 (3.5%)	2 (4.0%)
Walk	131 (21.6%)	29 (30.9%)	13 (22.8%)	12 (24.0%)
Unknown	92 (15.2%)	0 (0.0%)	1 (1.8%)	1 (2.0%)
Injection drug use
Yes	165 (27.2%)	77 (81.9%)	47 (82.5%)	40 (80.0%)
No	347 (57.2%)	15 (16.0%)	8 (14.0%)	8 (16.0%)
Unknown	95 (15.7%)	2 (2.1%)	2 (3.5%)	2 (4.0%)
Insurance
Medicaid/medicare	147 (24.2%)	22 (23.4%)	7 (12.3%)	6 (12.0%)
Private	104 (17.1%)	11 (11.7%)	6 (10.5%)	6 (12.0%)
Uninsured	260 (42.8%)	52 (55.3%)	38 (66.7%)	32 (64.0%)
Unknown	96 (15.8%)	9 (9.6%)	6 (10.5%)	6 (12.0%)